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AbstrACt
Objectives We examine the mortality of men and women 
within the first year after all-cause and cause-specific 
hospital admission to investigate whether the sex 
differences in mortality after hospitalisation are higher 
than in the corresponding general and non-hospitalised 
population.
Design This is a population-based, longitudinal study with 
nationwide coverage. The study population was identified 
by linking the National Patient Register with the Central 
Population Register using a 5% random sample of the 
Danish population.
setting The population born between 1898 and 1961, 
who was alive and residing in Denmark after 1977, was 
followed up between 1977 and 2011 with respect to 
hospital admissions and mortality while aged 50–79.
Primary outcome measures The absolute sex 
differences in the 1-year risk of dying after all-cause 
and cause-specific hospital admission. The hospitalised 
population sex differentials were then compared with 
the sex differences in a general and a non-hospitalised 
population, randomly matched by age, sex and 
hospitalisation status.
results The risk of dying was consistently higher for 
hospitalised men and women. At all ages, the absolute sex 
differences in mortality were largest in the hospitalised 
population, were smaller in the general population and 
were smallest in the non-hospitalised population. This 
pattern was consistent across all-cause admissions, and 
with respect to admissions for neoplasms, circulatory 
diseases and respiratory diseases. For all-cause hospital 
admissions, absolute sex differences in the 1-year risk 
of dying resulted in 43.8 excess male deaths per 1,000 
individuals within the age range 50–79, while the levels 
were lower in the general and the non-hospitalised 
population, at levels of 13.5 and 6.6, respectively.
Conclusions This study indicates a larger male 
disadvantage in mortality following hospitalisation, pointing 
towards an association between the health status of a 
population and the magnitude of the female advantage in 
mortality.
bACkgrOunD 
Empirical studies have consistently reported 
that women have a mortality advantage at all 
ages, starting at infancy and extending over 
the entire life course.1 Women have lower 
rates of mortality than men for nearly all 
causes of death, including most cancers,2–4 
respiratory diseases5 6 and accidents.7 More-
over, the female advantage in mortality 
persists even after stressful events during the 
life course, such as bereavement8 9 or famines 
and epidemics.10 While the relative sex differ-
ences in mortality peak at around age 25 
and tend to become smaller with age,11 the 
absolute sex differences grow almost expo-
nentially between ages 40 and 90, as general 
levels of mortality increase.12 Thus, in recent 
decades, the largest share of the sex differ-
ences in life expectancy has been attributed 
to mortality differentials after the age of 
strengths and limitations of this study
 ► This study uses high-quality Danish register data, 
with nationwide coverage, that leave little room 
for selection bias due to non-response or loss to 
follow-up.
 ► Our findings of excess male mortality within the first 
year after all-cause hospitalisation compared with 
their female counterparts remain robust when strat-
ifying by the main causes of admission to hospital 
in Denmark.
 ► Due to a lack of further medical data on the ad-
missions, including information on risk factors 
and severity of diseases, we were not able to dis-
entangle the potential behavioural and biological 
mechanisms behind widening sex differences after 
hospitalisation.
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5013—when individuals start to accumulate disease and 
disabilities, and the incidence of most adverse health 
conditions increases.14 
A number of previous studies have argued that a 
hospital admission may serve as a quasi-objective indicator 
of health. An admission to the hospital may indicate the 
onset of a health decline or the manifestation of a health 
decline that started long ago that now requires extensive 
medical interventions.15–17 The use of hospitalisation as a 
proxy for health is supported by previous research find-
ings showing that adults of all ages who rate their health 
and their quality of life as poor are at an increased risk of 
hospital admission.18–21 Furthermore, the well-established 
associations between major risk factors and the increased 
risk of dying from certain causes, such as smoking and 
lung cancer, have also been found for the relationship 
between risk factors and cause-specific reasons of admis-
sion.22–24 Empirical findings have demonstrated that 
smoking,22 hazardous drinking,25 being overweight,26 
having high cholesterol levels27 and a lack of physical 
activity28 are related to an increased risk of hospital 
admission. The presence of multiple risk factors has been 
found to be especially strongly associated with a high risk 
of admission.29
Although it has been well established that women have a 
mortality advantage across all ages and all causes of death, 
it is not yet known whether this advantage changes after 
the manifestation of bad health, which we measure as a 
hospital admission. To answer this question, we estimate 
the absolute sex differences in the 1-year risk of dying after 
all-cause and cause-specific hospital admission as an inpa-
tient. We compare these absolute sex differentials with 
the corresponding differences we would have observed in 
the general and the non-hospitalised population.
MethODs AnD MAteriAls
Data
This study uses a 5% random sample of the Danish popu-
lation. Using the unique personal identification number 
that is assigned to all individuals residing in Denmark,30 
we linked records from the National Patient Register 
(NPR) with data of the Central Population Registry 
(CPR). The CPR, which covers the entire population 
alive and residing in Denmark since 1968, contains infor-
mation on each resident’s vital status, sex and place and 
date of birth.31 The NPR is a population-based register 
with nationwide coverage that contains information on 
all admissions to hospitals since 1977.32 As reports to the 
administration are compulsory, the NPR data have high 
levels of completeness and reliability, making these data 
an excellent tool for research.33 Whereas data on hospital-
isations are available for the period 1977–2011, the vital 
status of individuals was traceable up to the year 2013. 
In the NPR, diagnoses were classified in accordance with 
the International Classification of Diseases (ICD), 8th 
Revision until 1993 and the ICD 10th Revision starting in 
1994.34 We classified the causes of admission to hospital 
according to the main chapters and using broad groups 
to reduce the potential bias, which may emerge from 
combining two systems of classification. An overview of 
the coding is given in online supplementary table 1–S.
study population
We identified all individuals who were born between 
1 January 1898 and 31 December 1961, who were alive 
and who resided in Denmark after 1968 in the 5% 
random sample (n=214,613). Of those, we then selected 
all individuals who survived up to age 50 and resided in 
Denmark after 1 January 1977 (n=198,580). Out of all 
remaining individuals, 64.3% (n=127,642) of the sample 
had been admitted to the hospital at least once between 
1 January 1977 and 31 December 2011. Hospitalisation 
was defined as the first time an individual was admitted 
to the hospital while aged 50–79 as an inpatient, for at 
least one night and for any reason between the years 
1977 and 2011. Subsequent admissions and admissions 
that occurred among these individuals before the age of 
50, after age 79 and before 1977—for the same or other 
causes—were not taken into account.
To examine whether the sex differences in mortality 
increase following an admission to hospital, we compared 
the sex differentials after hospitalisation with the corre-
sponding differences measured among two healthier 
references. For this purpose, two matched populations 
aged 50–79 were selected randomly from the study 
sample: one group to represent the general population, 
and the other group to represent the non-hospitalised 
population. Each hospitalised individual was matched to 
one individual from each reference group. The matched 
individuals forming the two reference populations had to 
be the same age (+/− 30 days), the same sex and alive 
on the day the corresponding case was hospitalised. 
Whereas the individuals representing the general popu-
lation were selected irrespective of hospitalisation status, 
the individuals representing the non-hospitalised popula-
tion had not been hospitalised within a concordant year 
before and after the exact date the corresponding case 
was admitted to the hospital, irrespective of the case’s 
cause of admission. Cases and matches were drawn from 
the same source population. We used matching with 
replacement to correct the observed distortion that a 
certain proportion of the hospitalised population would 
have remained without a match, which emerged when 
matching without replacement was tested. The matching 
was carried out 100 times to increase the robustness of 
the matching results, and to bypass the need to choose a 
single matching scenario. Consequently, the same person 
may appear more than once in each of the 100 matching 
scenarios.
Patient and public involvement
No patients were involved in setting the research ques-
tion or the outcome measures, nor were they involved 
in developing plans for design or implementation of the 
study. No patients were asked to advise on interpretation 
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or writing up of results. No patients were involved in the 
recruitment to and conduct of the study. There are no 
plans to disseminate the results of the research to study 
participants or the relevant patient community.
statistical analysis
The survival time of the hospitalised individuals starts 
immediately with the day of the first all-cause hospital 
admission after age 50, which was recorded in the regis-
ters. No lag time or washout period was used to ensure 
that the immediate impact of the manifestation of bad 
health on the risk of dying was captured, implying that 
deaths during the index hospital stay are included in the 
mortality calculations. Analogously, the process time of 
the individuals of both reference populations starts on 
the day the corresponding case was hospitalised. The 
survival status of all individuals was followed up within 
1 year. If a person was alive by the end of the follow-up 
period or had migrated, this individual was considered 
as having no event. We used a generalised additive 
model (GAM) for binary data with a logit link. Unlike 
in generalised linear models, the linear predictor in the 
GAM is replaced by a sum of smoothing functions.35 36 
We used penalised B-splines, so-called P-splines, as basis 
functions in the regression to smooth over age.37 38 We 
modelled the age-specific 1-year risk of dying separately 
for the men and the women of each population by single 
years of age. For the hospitalised population, we further 
estimated separate models by cause of admission to 
hospital to investigate whether the female advantage in 
survival following hospitalisation varies across different 
causes of admission. While the data preparation and the 
merging of registries was carried out with STATA (V.15), 
all statistical analyses were performed in R (V.3.3.2).
results
Of the 127,642 individuals who were hospitalised, 49.9% 
(n=63,649) were men and 50.1% (n=63,993) were 
women. The mean age at hospitalisation was slightly lower 
among the men (61.7; SD=8.5) than among the women 
(62.0; SD=9.0). An overview on the causes of admission to 
hospital is provided in table 1. We found the distribution 
of causes of hospital admission to be different in men and 
in women. In comparison with men, women were more 
likely to be hospitalised due to neoplasms, diseases of the 
blood and blood-forming organs, endocrine, nutritional 
and metabolic diseases, diseases of the eye and adnexa, 
musculoskeletal disorders and diseases of the genitouri-
nary system. In contrast, more men were admitted due 
to ischaemic heart diseases, cerebrovascular diseases 
and other circulatory diseases, as well as due to respira-
tory and digestive diseases than women. We found only 
small sex differences in the distribution with respect to 
infectious and parasitic diseases, mental and behavioural 
Table 1 Overview of  causes of admission to hospital by sex
Cause of hospital admission
Men Women
Number Share in % Number Share in %
Infectious and parasitic diseases 980 1.54 1,012 1.58
Neoplasms 6,625 10.41 9,310 14.55
Diseases of the blood and blood-forming organs 266 0.42 401 0.63
Endocrine, nutritional and metabolic diseases 1,368 2.15 2,220 3.47
Mental and behavioural disorders 1,000 1.57 883 1.38
Diseases of the nervous system 1,434 2.25 1,382 2.16
Diseases of the eye and adnexa 1,026 1.61 1,464 2.29
Diseases of the ear and mastoid process 461 0.72 496 0.78
Ischaemic heart diseases 5,899 9.27 2,601 4.06
Cerebrovascular diseases 2,386 3.75 1,756 2.74
Other circulatory diseases 6,324 9.94 5,368 8.39
Respiratory diseases 3,785 5.95 3,233 5.05
Digestive diseases 8,368 13.15 6,166 9.64
Diseases of the skin and subcutaneous tissue 786 1.23 700 1.09
Musculoskeletal disorders 4,737 7.44 5,858 9.15
Diseases of the genitourinary system 4,680 7.35 6,968 10.89
Injuries, poisonings and accidents 6,466 10.16 7,228 11.29
All other diseases* 7,058 11.09 6,947 10.86
Total 63,649 100.00 63,993 100.00
*The largest groups among the category of all other diseases are symptoms, signs and abnormal clinical and laboratory findings (men: 
57.57%, women: 58.42%) and factors influencing the health status and contact with health services (men: 37.47%, women: 36.99%).
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disorders, diseases of the nervous system, diseases of the 
ear and mastoid process, diseases of the skin and subcuta-
neous tissue as well as injuries, poisonings and accidents.
An overview of the three populations is given in table 2. 
While the data for the hospitalised population represent 
the exact number of observed cases, the numbers for the 
general and the non-hospitalised population refer to the 
mean of 100 matched samples. Because the matched indi-
viduals were of the same age and the same sex as the corre-
sponding cases, the three populations had identical age 
structures (mean=61.9, SD=8.9) and sex ratios. We found 
that the risk of dying was highest among the men and the 
women of the hospitalised population at the level of 9.42% 
(95% CI 9.26% to 9.58%). The risk of dying was substan-
tially lower and at the level of 1.98% (95% CI 1.90% to 
2.05%) in the corresponding general population, and 
lowest among the non-hospitalised population at a level of 
0.80% (95% CI 0.75% to 0.85%), respectively. As shown in 
table 2, men had consistently higher mortality than women 
in all of the three populations. In all populations, we found 
the mortality of both sexes to increase consistently with age.
We further estimated the risk of dying and the trajec-
tory of this risk by single years of age for men and women 
in each population and corresponding 95% CI using a 
non-parametric GAM. As shown in figure 1, we found that 
men had consistently higher mortality than their female 
counterparts in each population, at all ages and for 
admissions due to all causes, neoplasms, circulatory and 
respiratory diseases. The risk of dying increased consis-
tently with age among the men and the women in each 
population, and with respect to all causes of admission to 
hospital
At the age of 50, the 1-year risk of dying for all-cause 
admissions in the hospitalised population was 5.17% 
(95% CI 4.60% to 5.73%) for men and 2.97% (95% CI 
2.66% to 3.29%) for women. With age, the risk of dying 
increased and reached a level of 26.61% (95% CI 24.08% 
to 29.13%) and 19.12% (95% CI 17.65% to 20.60%) 
Table 2 Number of individuals, number of deaths and the risk of dying within 1 year of follow-up by sex and age in the 
hospitalised, general and non-hospitalised population




Individuals Deaths Individuals Deaths
No. Share in % No. Risk in % No. Share in % No. Risk in %
Hospitalised population
  50–54 18,397 28.90 906 4.92 19,569 30.58 622 3.18
  55–59 12,392 19.47 898 7.25 11,432 17.86 514 4.50
  60–64 10,493 16.49 1,074 10.24 9,244 14.45 655 7.09
  65–69 9,030 14.19 1,320 14.62 8,508 13.30 844 9.92
  70–74 7,623 11.98 1,432 18.79 7,967 12.45 1,046 13.13
  75–79 5,714 8.98 1,457 25.50 7,273 11.37 1,261 17.34
  Total 63,649 100.00 7,087 11.13 63,993 100.00 4,942 7.72
General population*
  50–54 18,400 28.91 124 0.68 19,558 30.56 88 0.45
  55–59 12,394 19.47 145 1.17 11,452 17.90 80 0.70
  60–64 10,486 16.47 195 1.86 9,231 14.43 100 1.08
  65–69 9,042 14.21 268 2.97 8,520 13.31 153 1.80
  70–74 7,612 11.96 369 4.85 7,961 12.44 218 2.74
  75–79 5,714 8.98 449 7.85 7,270 11.36 334 4.60
  Total 63,649 100.00 1,551 2.44 63,993 100.00 974 1.52
Non-hospitalised population*
  50–54 18,400 28.91 57 0.31 19,558 30.56 27 0.14
  55–59 12,393 19.47 53 0.43 11,452 17.90 21 0.18
  60–64 10,488 16.48 76 0.72 9,232 14.43 32 0.34
  65–69 9,042 14.21 108 1.20 8,521 13.32 52 0.61
  70–74 7,612 11.96 150 1.97 7,958 12.44 83 1.05
  75–79 5,713 8.98 150 2.63 7,271 11.36 154 2.12
  Total 63,649 100.00 656 1.03 63,993 100.00 369 0.58
*The number of deaths and the risk of dying refers to the average of 100 matching results.
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among 79-year-old men and women of the hospitalised 
population, respectively.
We found the absolute increase in mortality with age to 
be smaller in the general population than in the hospi-
talised population. Starting with levels of 0.47% (95% CI 
0.46% to 0.49%) among men and 0.39% (95% CI 0.38% 
to 0.41%) among women at age 50, the risk of dying was 
9.30% (95% CI 9.12% to 9.47%) and 5.61% (95% CI 
5.49% to 5.73%) at the age of 79 in the general popula-
tion, respectively.
We found the non-hospitalised population to have the 
lowest absolute increase in mortality with age: at age 50, 
the risk of dying was 0.25% (95% CI 0.24% to 0.26%) for 
men and 0.12% (95% CI 0.11% to 0.13%) for women, 
and it increased to 4.54% (95% CI 4.42% to 4.67%) and 
2.52% (95% CI 2.43% to 2.60%) at age 79, respectively.
In a next step, we calculated the absolute sex differ-
ences in the 1-year risk of dying and the the male excess 
mortality per 1,000 persons. Figure 2 shows the age 
trajectory of the male excess mortality in each of the 
three populations and by cause of admission to hospital. 
At all ages and regarding admissions for all causes, 
neoplasms, circulatory and respiratory diseases, the 
absolute sex differences were largest in the hospitalised 
population, were smaller in the general population, and 
were smallest in the non-hospitalised population. At age 
50 and for all-cause admissions, the sex differences in 
survival resulted in 22.0 excess male deaths per 1,000 indi-
viduals in the hospitalised population, while there were 
0.8 excess male deaths in the general population and 1.3 
excess male deaths in the non-hospitalised population. 
Within the observed age range, the excess male mortality 
increased almost steadily among all three populations, 
resulting at levels of 42.0, 9.8 and 4.8 excess male deaths 
per 1,000 individuals at age 65, and levels of 74.8, 36.9 
and 20.3 at age 79, respectively. For all-cause hospital 
admissions, the larger absolute sex differences in the 
1-year risk of dying resulted, on average, in 43.8 excess 
male deaths per 1000 individuals within the age range 
50–79, while the levels were lower in the general and the 
non-hospitalised population, and at levels of 13.5 and 
6.6, respectively. While the male excess mortality after 
all-cause hospital admission increases steadily with age, 
the pattern differs when broken down by specific causes 
of admission. Whereas for admissions due to circulatory 
and respiratory diseases the male excess mortality shows 
Figure 1 Estimated age trajectories in the risk of dying within 1 year of follow-up by cause of admission to hospital.
 on A









pen: first published as 10.1136/bm




6 Höhn A, et al. BMJ Open 2018;8:e021813. doi:10.1136/bmjopen-2018-021813
Open access 
a similar increasing pattern, the male excess mortality is 
highest at younger ages for admissions due to neoplasms 
and decreases with age.
DisCussiOn
In this study, we investigated how women’s mortality 
advantage changes after the manifestation of an adverse 
health condition, which we measured as a hospital 
admission. We estimated the absolute sex differences in 
the 1-year risk of dying after an all-cause and cause-spe-
cific hospitalisation among the population aged 50–79, 
and compared these patterns with those observed in a 
matched general and non-hospitalised population. As 
expected, women had consistently lower mortality than 
men in all three populations. In addition, we found that 
the absolute sex differences in mortality were highest for 
the hospitalised population, were lower in the general 
population and were lowest in the non-hospitalised popu-
lation. The excess of male mortality always remained 
larger in the hospitalised population also when differenti-
ating by cause of admission to hospital.
strengths and weaknesses of the study
In this study, we used Danish register data, which provide 
nationwide coverage and are representative of the total 
Danish population. In contrast to longitudinal survey 
data, these register data suffer less in terms of non-re-
sponse and loss to follow-up; issues that could have 
biased the analyses and led to skewed results.39 Another 
strength is that we were able to examine mortality for 
the overarching all-cause hospital admissions as well as 
the mortality patterns for cause-specific hospital admis-
sions. This allowed us to establish if the larger male 
excess mortality following hospitalisation was present 
across different causes of hospital admission, repre-
senting admissions for the major causes of death in 
Denmark. Similar patterns of sex differences in all-cause 
and cause-specific admissions suggest that the larger sex 
differences in mortality after hospital admission cannot 
be fully explained by differences in the distribution of 
causes of admission among men and women. In order to 
minimise the bias due to changes in ICD coding over the 
study period, we used broad categories to group causes 
of hospital admission.
Figure 2 Male excess mortality within 1 year of follow-up by cause of admission to hospital.
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We calculated the absolute sex differences in the 
1-year risk of dying after an admission to hospital. This 
allowed us to directly compare the male excess mortality 
in the hospitalised, the general and the non-hospitalised 
population. It has been shown that different conclusions 
about health inequalities might be the result of the effect 
measure used. This has been shown in relation to mortality 
differences between socioeconomic groups, across coun-
tries, over time40 and in respect to sex differences.12 41 
We therefore replicated the analysis using risk ratios (see 
online supplementary figure 1–S). Using risk ratios leads 
to a different interpretation, that the sex differences were 
lowest among the hospitalised individuals and highest 
for the non-hospitalised population where the overall 
risk of mortality was lowest. Both, absolute and relative 
measures are context dependent and their use needs 
to be justified.40 Problems surrounding the interpreta-
tion of risk ratios often appear when populations under 
investigation differ in their overall risks of mortality.12 In 
our case, the discrepancy between absolute and relative 
measures is driven by the fact that the three populations 
differ significantly in their initial levels of mortality. As 
we are interested in quantifying the burden of the male 
excess mortality across the three populations, an abso-
lute measure appears to be most suitable as it takes into 
account the underlying risks of mortality.42
Our study does not address the underlying reasons for 
the greater excess male mortality in the 1-year period 
after admission to hospital. The register data did not 
allow us to examine the severity of the underlying causes 
of hospital admission and to control for differences in 
health behaviours. Furthermore, the study design did not 
allow us to examine the question of whether the observed 
gaps in survival after hospital admission changed over 
time or across cohorts. This issue may be particularly 
relevant for Denmark where the sex differentials in 
mortality are known to have been affected by a stagnation 
of female life expectancy during the 1977–1995 period, 
which was a consequence of smoking among women born 
between the two World Wars.43–45 The increased preva-
lence of smoking among Danish women, when compared 
with countries where the prevalence of female smokers 
remained low throughout the 20th century, may have 
an impact on our findings in two ways. First, by leading 
to higher levels of mortality among women of all three 
populations. Second, by leading to higher rates of admis-
sions for smoking-related diseases among women. Likely, 
the male excess mortality would have been higher in 
all three populations in the absence of higher smoking 
rates among Danish women. The data do not allow us 
to quantify the impact of the Danish smoking phenom-
enon on our findings. All in all, this demonstrates that 
factors which determine the distribution of causes of 
admission to hospital and the levels of disease-specific 
mortality after hospitalisation within a population are 
complex. Both factors may be influenced by changes in 
the organisation and the performance of the healthcare 
system, including shifts in the admission strategies and 
the quality of medical treatment; or they could depend 
on a range of demographic characteristics, such as the 
prevalence of diseases or the distribution of risk factors 
in a population.22
It is important to highlight that our analysis compares 
men and women of the same age and does not control 
for the health status of individuals. However, we recognise 
that men tend to develop adverse health conditions at 
earlier ages than women,46 47 and that studies on strokes 
and myocardial infarctions have shown that, on average, 
men are 8 years younger than women at the onset of these 
conditions.48–51
To gain a deeper understanding of the sex differences 
in mortality after hospital admission, future research 
should aim to identify the underlying reasons for these 
differences, and investigate how these sex disparities 
have developed over time, by cohort, and how they vary 
by socioeconomic status. Also, the length of follow-up 
we used needs to be taken into account. It could be that 
the increased level of mortality during the first year after 
admission is temporary and that the duration of the 
follow-up period has an impact on the mortality levels 
of the hospitalised men and women due to selective 
mortality and cure. As we wanted to capture the imme-
diate mortality development following hospital admis-
sion, we decided to use a relatively short follow-up period 
of 1-year length.
interpretation and implications in light of previous findings
The existing literature focusing on the female mortality 
advantage has pointed towards the effects and the inter-
actions of biological, behavioural and social factors.39 The 
most widely cited biological factors are hormonal, based 
on the observation that the female hormone oestrogen 
has favourable effects on serum lipid levels, as well as 
vasoprotective and immune-enhancing effects, and 
genetic, based on the assumption that women’s second 
X chromosome helps to ameliorate the harmful effects 
of gene mutations on the X chromosome.52–55 Moreover, 
women may have stronger immune systems than men, 
which could help women to recover more quickly,56 and 
may play a fundamental role in women’s better survival 
of harsh conditions, including famines and epidemics.10 
In addition to these biological factors, researchers have 
attributed a portion of the male disadvantage in mortality 
to behavioural and social factors.57 For example, it has 
been argued that men have higher rates than women of 
smoking, excessive drinking, drug use and violence.58 In 
addition to this, a large body of previous research, 
including research for Denmark, has shown that men 
tend to seek medical help later than women, which can 
lead to delays in diagnosis and treatment.59–65 Previous 
studies have shown that men who are hospitalised tend to 
have conditions that are more severe and diseases are at 
more advanced stages than those of the women who are 
hospitalised; although the reasons for this pattern have 
not yet been fully understood.66
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In Denmark, hospital care is financed through taxes, 
and is thus available to all residents, regardless of their sex 
and socioeconomic characteristics.67 Although our results 
may have been affected by changes in policies related to 
hospital admission, treatment and discharge, it is likely 
that such changes would have affected men and women 
in similar ways. Although access to healthcare services is 
free and universal in Denmark, individuals may encounter 
hurdles in accessing healthcare services for a variety of 
reasons, including social, economic, demographic and 
geographic factors.68 In Denmark, general practitioners 
(GPs) typically serve not just as gatekeepers for the use 
of secondary healthcare but also as care providers who 
can help patients avoid or postpone an admission to the 
hospital. For example, GPs assist patients in monitoring 
their health and in preventing the progress of many 
chronic conditions through regular medical check-ups, 
health consultations, the prescription of medications 
and other preventive measures.69 It is possible that the 
higher excess mortality after hospital admission among 
men, found in our study, may be partially explained by 
sex differences in health awareness and help-seeking 
long before an adverse health condition becomes visible. 
Thus, the female advantage in survival after hospital 
admission is likely to be due to multiple factors, including 
biological advantages underpinned by sex differences in 
health behaviours. Our findings point towards the impor-
tance of further research on the possibilities of an effi-
cient primary healthcare system, as well as individuals’ 
awareness of diseases, risk factors and compliance with 
preventive measures to reduce the male excess mortality 
following the manifestation of bad health.
COnClusiOn
In this study, we found that the risk of dying was highest 
for the hospitalised men and women in the 1-year period 
after admission to hospital, was lower among their coun-
terparts in the general population and was lowest among 
those individuals who were not admitted to the hospital. 
We found the male excess mortality to be larger after 
the manifestation of bad health, which we measured as a 
hospital admission. Our findings point towards an associ-
ation between the health status of a population and the 
magnitude of the absolute female advantage in mortality.
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